Antimalarial drug confirmed effective on COVID-19

Sun, Y., deputy head of the China National Center for Biotechnology Development, Feb 2020

HCQ for COVID-19

1st treatment shown to reduce risk in March 2020, now with p < 0.0000000001 from 426 studies, used in 59 countries.

No treatment is 100% effective.
Protocols combine treatments.

HCQ under clinical trials in >10 hospitals in China and has shown fairly good efficacy.
Sun et al., 17 Feb 2020, preprint, 1 author.
Late treatment
is less effective